CN Patent

CN100339072C — 一种美索巴莫干混悬剂

Assigned to Tianjin Hankang Pharmaceutical Biotechnology Co Ltd · Expires 2007-09-26 · 19y expired

What this patent protects

本发明涉及一种美索巴莫干混悬剂，含有有效量的活性组分美索巴莫和适合制备干混悬剂型的药物可接受的载体，所述适合制备干混悬剂型的药物可接受的载体包括纤维素衍生物，矫味剂，粘合剂，其中纤维素衍生物优选的是羟丙甲基纤维素，微晶纤维素，矫味剂优选的是蔗糖，粘合剂优选的是乙醇和水的混合物。

USPTO Abstract

本发明涉及一种美索巴莫干混悬剂，含有有效量的活性组分美索巴莫和适合制备干混悬剂型的药物可接受的载体，所述适合制备干混悬剂型的药物可接受的载体包括纤维素衍生物，矫味剂，粘合剂，其中纤维素衍生物优选的是羟丙甲基纤维素，微晶纤维素，矫味剂优选的是蔗糖，粘合剂优选的是乙醇和水的混合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN100339072C
Jurisdiction
CN
Classification
—
Expires
2007-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Hankang Pharmaceutical Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.